Why the study?
Does a combination of warfarin, trypsin-chymotrypsin enzymes, and aspirin improve outcomes in patients with extensive acute deep thrombophlebitis?
Does a combination of warfarin, trypsin-chymotrypsin enzymes, and aspirin improve outcomes in patients with extensive acute deep thrombophlebitis?
A preliminary report suggests that a triple therapy combination of warfarin, trypsin-chymotrypsin, and aspirin may be a safe and effective treatment for extensive thrombophlebitis.
Answers are grounded in this paper and cite their sources.
Does not support routine use; hypothesis-generating for triple therapy in extensive thrombophlebitis.
Therapy for patients with extensive thrombophlebitis is ofter inadequate with available methods. The reluctance of most physicians in private practice to use streptokinase or urokinase is understandable when one considers the cost, hospitalization, length of stay and risks involved. This article discusses a unique and previously unreported mode of drug therapy in these patients, consisting of a combination of drugs designed to combine the antithrombotic and thrombusantipropagating effects of warfarin, the anti-inflammatory effect of trypsin-chymotrypsin enzymes, and the antiplatelet aggregating, antiadhesion, and possible enhanced fibrinolytic effects of aspirin with added buffered protection (Ascriptin A/D). This treatment program has been a safe, efficient, economical, and highly effective one for a very costly, common, and disabling disease. It therefore fulfills the ideal criteria for any form of therapy, provided one is knowledgable of its content, and adheres to its contraindications as well as to the basic application of the drugs involved. It is hoped that further investigations along these lines will continue until an ideal solution is reached. Although this is a preliminary report, this study will continue in its present form, and will be expanded to include a series of patients on the aspirin-enzyme combination without the use of warfarin.
No takes yet. Share an insight, caveat, or question.
Basil M. RuDusky (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: